Live Breaking News & Updates on Leopold Bertea

Stay updated with breaking news from Leopold bertea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mendus to present at Cell & Gene Therapy Manufacturing & Commercialization Conference in Dublin on December 4-6

Press Release Stockholm, Sweden, December 5, 2023 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced it will present the. ....

United States , Erik Manting , Leopold Bertea , American Society Of Hematology , Gene Therapy Manufacturing , Commercialization Conference , Chief Technology Officer Leopold Bertea , Cell Therapy Manufacturing , Northx Biologics , Robust Industrial Manufacturing Process , Cancer Maintenance Treatment , Nasdaq Stockholm , American Society , Orphan Drug Designation , Fast Track Designation ,

Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX. ....

City Of , United Kingdom , United States , San Diego , San Diego Convention Center , France General , Corey Davis , Erik Manting , Mario Brkulj , Lotta Ferm , Leopold Bertea , Lifesci Advisors , Society For The Immunotherapy Of Cancer , Nordic Congress , Valency Communications , Company Update , Nasdaq Stockholm , Sci Advisors ,

Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel

POSITIVE RECOMMENDATION BY COMMITTEE FOR ADVANCED THERAPIES CONFIRMS QUALITY OF THE MANUFACTURING PROCESS AND PRECLINICAL DATA SUBMITTED Mendus AB , a biopharmaceutical company focused on. | June 19, 2023 ....

Erik Manting , Mario Brkulj , Leopold Bertea , Corey Davis , European Medicines Agency , Valency Communications , Committee For Advanced Therapies , Lifesci Advisors , Advanced Therapy Medicinal Product , Advanced Therapies , Chief Technology Officer , Nasdaq Stockholm , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Ocused Immu Se0005003654 ,

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a. | June 8, 2023 ....

City Of , United Kingdom , Corey Davis , Erik Manting , Helena Strig , Van Herk , Mario Brkulj , Leopold Bertea , Thomas Eldered , Manufacturing Organization , Valency Communications , Contract Development , National Swedish Innovation Hub , Fourth Swedish National Pension Fund , Lifesci Advisors , Northx Biologics , Flerie Invest , Van Herk Investments , Chief Executive Officer , Mendu Board , Extraordinary General Meeting , Acute Myeloid Leukemia , Chief Technology Officer , Sci Advisors , Nasdaq Stockholm , Mendus Ab Publ Stock Exchange ,

Mendus AB: Mendus secures manufacturing partner for establishing potential pivotal trial-stage and commercial production of DCP-001

TECH TRANSFER ALIGNS WITH CLINICAL DEVELOPMENT STRATEGY FOR DCP-001 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced an agreement to. | October 18, 2022 ....

Mario Brkulj , Erik Manting , Leopold Bertea , Corey Davis , Lifesci Advisors , European Society Of Gynecological Oncology , Valency Communications , Minaris Regenerative Medicine Gmbh , Acute Myeloid Leukemia , Chief Technology Officer , European Society , Gynecological Oncology , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Greement Immu Se0005003654 ,